510(k) · Cleared

Cleared

Care Tens

K984025510(k) TraditionalCleared Feb 10, 199990-day reviewClass II21 CFR 882.5890

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Care Rehab, Inc. · GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

Cleared on Feb 10, 1999 as substantially equivalent to K895473 (Medical Devices, Inc., 1989) after a 90-day review. Its family tree reaches back 1 generation to 1989.

Decided: Feb 10, 1999
Review: 90 days
Class: Class II
Product code: GZJ
Recalls: None
Predicates: 1

Its longest line of descent runs back 1 generation to K895473 (1989). No later device cites it as a predicate yet.

By dateBy generation

Root · 1 generation backK895473 DSX (TM), Digital SX, Quantum DSX, Model 4700SMedical Devices, Inc. · 1989
This deviceK984025 Care TensCare Rehab, Inc. · 1999

View FIG. 1 as a table

Line of descent and top descendants

Generation	Number	Device	Applicant	Decided	Recalls
−1	K895473	DSX (TM), Digital SX, Quantum DSX, Model 4700S	Medical Devices, Inc.	1989	—
0 (this device)	K984025	Care Tens	Care Rehab, Inc.	1999	—

FIG. 1 — Lineage of K984025, 1989–1999Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GZJ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GZJ device

#1 K252767 actiTENS miniscore 13.1 · 9 generations · no Class I recall
#2 Held for the reportin the report
#3 Held for the reportin the report

Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

Type	Number	Device	Applicant	Decided	Recalls
*	K895473	DSX (TM), Digital SX, Quantum DSX, Model 4700S Summary page 1 …703-448-9644 FAX: 1-703-356-2182. November 9, 1998 CARE TENS™ TENS device Stimulator, Nerve, Transcutaneous, For Pain Relief 84GZI; 21 CFR 882.5890. Class I Matrix I (K895473) A portable TENS device for pain control. TENS is used for symptomatic relief and management of chronic intractable pain and/or…	Medical Devices, Inc.	1989	—

Also cleared against K895473: 3 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

Its one ancestor has no recall.
3 other devices also cite its predicate K895473.

How does its category compare?

All GZJ devices

GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · GZJ

1in 2025

2007high 16 (2009) · low 1 (2023)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GZJ

207in 2024

2007high 344 (2014) · low 113 (2017)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GZJ

1in 2011

2007high 4 (2007) · low 0 (2009)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · GZJ

13in 2025

2007high 58 (2017) · low 4 (2007)2025

MAUDE reports naming product code GZJ, not matched to any one device; reports are not rates.

View these four charts as a table

Year	Decisions	Median 510(k) review, days	Recalls (Class I)	MAUDE reports
2007	13	223	4	4
2008	11	136	1	45
2009	16	155	0	17
2010	5	232	0	22
2011	5	168	1	22
2012	12	154	0	20
2013	2	—	0	10
2014	4	344	0	23
2015	3	202	0	18
2016	3	163	0	32
2017	3	113	0	58
2018	2	—	0	21
2019	3	156	0	7
2020	4	183	0	10
2021	3	231	0	5
2022	4	175	0	4
2023	1	—	0	39
2024	3	207	0	12
2025	1	—	0	13
2026	2	—	0	—

What is it indicated for?

TENS is used for symptomatic relief and management of chronic intractable pain and/or as an adjunctive treatment in the management of postsurgical and posttraumatic acute pain.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

https://510kreport.com/device/K984025 · printed Nov 4, 2026

Cite this page

510(k) Report. “K984025: Care Tens.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K984025

Report an extraction error

Are you the manufacturer?

Record history

FDA decision record loaded May 2, 2026
Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
Lineage and recalls computed Nov 3, 2026
Page last updated Nov 3, 2026